Related Experiment Video
Updated: Jul 19, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Polymorphisms within inflammatory genes and colorectal cancer.
Stefano Landi1, Federica Gemignani, Fabio Bottari
1Genetics-Department of Biology, University of Pisa, via S, Giuseppe 22, 56126, Pisa, Italy. slandi@biologia.unipi.it
Journal of Negative Results in Biomedicine
|October 26, 2006
Summary
This study found no link between common gene variations in inflammation and colorectal cancer (CRC) risk. Larger sample sizes may be needed to detect subtle genetic effects on CRC development.
Area of Science:
- Genetics
- Oncology
- Inflammation Biology
Background:
- Chronic inflammation is a known risk factor for colorectal cancer (CRC).
- Genetic variations (polymorphisms) in inflammatory genes may influence inflammation levels and CRC susceptibility.
- This study focused on specific single nucleotide polymorphisms (SNPs) in key inflammation-related genes.
Purpose of the Study:
- To investigate the association between ten selected single nucleotide polymorphisms (SNPs) in inflammation-related genes and the risk of colorectal cancer (CRC).
- To determine if specific genetic variations in genes like TLR4, CD14, MCP1, IL12A, NOS2A, TNF, and PTGS1 are linked to CRC development.
Main Methods:
- Genotyping of ten single nucleotide polymorphisms (SNPs) in inflammation-related genes.
- Case-control study design involving 377 colorectal cancer (CRC) cases and 326 controls.
- Statistical analysis to assess the association between SNPs and CRC risk.
Main Results:
- No statistically significant association was found between any of the investigated single nucleotide polymorphisms (SNPs) and colorectal cancer (CRC) risk.
- The analyzed genetic variations in inflammatory genes did not appear to modify CRC risk in the studied population.
Conclusions:
- The selected inflammatory genes and their analyzed polymorphisms may not play a significant role in the carcinogenic process of the colorectum.
- The absence of detected associations could be due to a lack of biological effect, a very small effect size undetectable with the current sample size, or that these specific SNPs are not involved in CRC pathogenesis.
- Future research with larger sample sizes might be necessary to uncover potential subtle associations between inflammatory gene polymorphisms and colorectal cancer risk.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...